Home Cart 0 Sign in  

[ CAS No. 45644-21-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 45644-21-1
Chemical Structure| 45644-21-1
Structure of 45644-21-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 45644-21-1 ]

Related Doc. of [ 45644-21-1 ]

Alternatived Products of [ 45644-21-1 ]

Product Details of [ 45644-21-1 ]

CAS No. :45644-21-1 MDL No. :MFCD00234068
Formula : C5H5ClN2 Boiling Point : -
Linear Structure Formula :- InChI Key :OBYJTLDIQBWBHM-UHFFFAOYSA-N
M.W : 128.56 Pubchem ID :206246
Synonyms :

Calculated chemistry of [ 45644-21-1 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 33.65
TPSA : 38.91 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.49 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.32
Log Po/w (XLOGP3) : 0.84
Log Po/w (WLOGP) : 1.33
Log Po/w (MLOGP) : 0.81
Log Po/w (SILICOS-IT) : 1.37
Consensus Log Po/w : 1.13

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.72
Solubility : 2.44 mg/ml ; 0.019 mol/l
Class : Very soluble
Log S (Ali) : -1.24
Solubility : 7.4 mg/ml ; 0.0575 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.24
Solubility : 0.735 mg/ml ; 0.00571 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.61

Safety of [ 45644-21-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 45644-21-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 45644-21-1 ]
  • Downstream synthetic route of [ 45644-21-1 ]

[ 45644-21-1 ] Synthesis Path-Upstream   1~37

  • 1
  • [ 94166-64-0 ]
  • [ 45644-21-1 ]
YieldReaction ConditionsOperation in experiment
98% With sodium tetrahydroborate In ethanol; water at 20℃; for 1.5 h; General procedure: TAPEHA-Pd (0.015 g) was added to a solution of nitroarenes (1.0 mmol) in EtOH/water (1/1) (20 mL). After NaBH4 (4.0 mmol) was slowly added to the mixture, the color of the reaction mixture turned gradually black in a few minutes, resulting in the formation of palladium nanoparticles (TAPEHA-PdNPs). 42 After being stirredfor 1.5 h at room temperature and atmospheric pressure, the catalyst was removed by ltering and the fitrate was extracted with 3 30 mL of EtOAc. The combined organic layers were dried over MgSO4 and concentrated in a vacuum.
97% With sodium tetrahydroborate In ethanol; water at 20℃; for 4 h; General procedure: SAC (300mg) and NaBH4 (4.0mmol) were added to a solution of nitroarenes (1.0mmol) in EtOH/water (1/1) (20ml). The reaction mixture was stirred for 4h at the temperature indicated in Table3. At the end of the reaction, the catalyst was removed by filtering and the filtrate was extracted with 3×70ml EtOAc. The combined organic layers were dried over MgSO4 and concentrated in a vacuum.
Reference: [1] Turkish Journal of Chemistry, 2017, vol. 41, # 5, p. 784 - 792
[2] Catalysis Communications, 2015, vol. 67, p. 64 - 67
  • 2
  • [ 2402-78-0 ]
  • [ 45644-21-1 ]
YieldReaction ConditionsOperation in experiment
70% With ammonia In water at 150℃; for 6 h; In a 600 mL autoclave equipped with a gas entrapment stirrer 240 g aqueous ammonia (28percent NH3 by weight) was added and mixed with 120 g of 2, 6-dichloropyridine. After purging with nitrogen, 48 g of liquid ammonia were added, and the reaction mixture was heated to 150°C for 6 h under stirring. The reaction mixture was allowed to cool to room temperature, and the pressure was brought back to atmospheric pressure . The product was isolated by filtration, washed with water and MeOH and dried. The yield for 2-chloro-6-amino pyridine was about 70percent, and the purity as determined by GC chromatography was 98percent.
Reference: [1] Tetrahedron, 2002, vol. 58, # 3, p. 489 - 493
[2] Organic Process Research and Development, 2009, vol. 13, # 3, p. 555 - 566
[3] Patent: WO2009/18504, 2009, A1, . Location in patent: Page/Page column 18
[4] Journal of Medicinal Chemistry, 1987, vol. 30, # 11, p. 2047 - 2051
[5] Recueil des Travaux Chimiques des Pays-Bas, 1939, vol. 58, p. 709,721
[6] Patent: US2002/173490, 2002, A1,
[7] Patent: US6756360, 2004, B1, . Location in patent: Page column 145
[8] Patent: US6489476, 2002, B1,
  • 3
  • [ 2402-78-0 ]
  • [ 141-86-6 ]
  • [ 45644-21-1 ]
YieldReaction ConditionsOperation in experiment
91 %Chromat. With ammonium acetate; ammonia In water at 150℃; for 8 h; In a 600 mL autoclave equipped with a gas entrapment stirrer, a solution of 5 g CuI in 120 g aqueous ammonia (30percent NH3 by weight) was added and mixed with 77 g ammonium acetate and 60 g of 2, 6-dichloropyridine. After purging with nitrogen, 24 g of liquid ammonia were added resulting in a pressure of about 150 psi (1.03 MPa). Subsequently, the reaction mixture was heated to 150°C for 8 h under stirring. Over the course of the reaction, the pressure decreased from an initial pressure of 680 psi (4.69 MPa) to 450 psi (3.10 MPa). The reaction mixture was allowed to cool to room temperature, and the pressure was brought back to atmospheric pressure. The reaction mixture was analyzed using a quantitative GC analytical method. The conversion of 2, 6-dichloropyridine was greater than 99.5percent. The reaction mixture contained 0.37 mol 2,6- diaminopyridine and 0.03 mol 2-chloro-6-amino pyridine. The yields for 2, 6-diaminopyridine and 2-chloro-6-amino pyridine were 91percent and 7percent, respectively.
72 %Chromat. With ammonia In water at 150℃; for 8 h; This reaction was conducted in the same manner as described in Example 1, but no ammonium acetate was added to the reaction mixture, demonstrating that lower selectivity is obtained in an unbuffered solution. The conversion of 2, 6-dichloropyridine was greater than 99.5percent. The reaction mixture contained 0.29 mol 2, 6-diaminopyridine and less than 0.005 mol 2-chloro-6-amino pyridine. The yield for 2, 6-diaminopyridine was 72percent.
Reference: [1] Patent: WO2009/18502, 2009, A2, . Location in patent: Page/Page column 18
[2] Patent: WO2009/18502, 2009, A2, . Location in patent: Page/Page column 19
  • 4
  • [ 20885-12-5 ]
  • [ 45644-21-1 ]
Reference: [1] Organic and Biomolecular Chemistry, 2018, vol. 16, # 41, p. 7564 - 7567
  • 5
  • [ 80364-46-1 ]
  • [ 45644-21-1 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1981, vol. 18, # 5, p. 1007 - 1010
  • 6
  • [ 13880-89-2 ]
  • [ 45644-21-1 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1981, vol. 18, # 5, p. 1007 - 1010
  • 7
  • [ 74405-06-4 ]
  • [ 45644-21-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1980, vol. 28, # 2, p. 465 - 472
  • 8
  • [ 1075-62-3 ]
  • [ 45644-21-1 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1981, vol. 18, # 5, p. 1007 - 1010
  • 9
  • [ 98130-68-8 ]
  • [ 45644-21-1 ]
  • [ 99973-81-6 ]
Reference: [1] Journal of Organic Chemistry, 1958, vol. 23, p. 1287
  • 10
  • [ 159603-71-1 ]
  • [ 45644-21-1 ]
Reference: [1] Australian Journal of Chemistry, 1982, vol. 35, # 10, p. 2025 - 2034
  • 11
  • [ 4684-94-0 ]
  • [ 45644-21-1 ]
Reference: [1] Australian Journal of Chemistry, 1982, vol. 35, # 10, p. 2025 - 2034
  • 12
  • [ 110-86-1 ]
  • [ 45644-21-1 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1939, vol. 58, p. 709,721
  • 13
  • [ 909394-40-7 ]
  • [ 27757-85-3 ]
  • [ 45644-21-1 ]
Reference: [1] Monatshefte fur Chemie, 2006, vol. 137, # 3, p. 285 - 299
  • 14
  • [ 909394-42-9 ]
  • [ 45644-21-1 ]
  • [ 932-30-9 ]
Reference: [1] Monatshefte fur Chemie, 2006, vol. 137, # 3, p. 285 - 299
  • 15
  • [ 909394-43-0 ]
  • [ 45644-21-1 ]
  • [ 89985-53-5 ]
Reference: [1] Monatshefte fur Chemie, 2006, vol. 137, # 3, p. 285 - 299
  • 16
  • [ 909394-44-1 ]
  • [ 45644-21-1 ]
  • [ 5386-23-2 ]
Reference: [1] Monatshefte fur Chemie, 2006, vol. 137, # 3, p. 285 - 299
  • 17
  • [ 45644-21-1 ]
  • [ 557-20-0 ]
  • [ 21717-29-3 ]
Reference: [1] Patent: WO2011/112995, 2011, A1, . Location in patent: Page/Page column 69
[2] Patent: US2014/148430, 2014, A1, . Location in patent: Paragraph 0372
  • 18
  • [ 45644-21-1 ]
  • [ 124-41-4 ]
  • [ 17920-35-3 ]
Reference: [1] Australian Journal of Chemistry, 1982, vol. 35, # 10, p. 2025 - 2034
  • 19
  • [ 45644-21-1 ]
  • [ 98-80-6 ]
  • [ 39774-25-9 ]
YieldReaction ConditionsOperation in experiment
82% With potassium phosphate; 1,1'-bis(di-tertbutylphosphino)ferrocene; palladium diacetate In 1,4-dioxane at 100℃; for 5 h; Inert atmosphere; Sealed tube General procedure: To a solution of the requisite chloro-amino-substituted heteroaromatic in anhydrous 1,4-dioxane (30 volumes wrt chloride) in a sealed tube was introduced phenylboronic acid (1.5 equiv) and finely ground potassium phosphate (2.0 equiv). The solution was degassed (N2 bubbling) for 5 min, Pd(OAc)2 (5 mol percent wrt chloride) and di-tert-butylphosphinoferrocene (5 mol percent wrt chloride) introduced and degassing continued for a further 5 min. The tube was sealed under nitrogen and heated with rapid stirring at 100 °C for 5 h. After cooling, the reaction mixture was filtered in vacuo through a celite pad and the precipitated material washed with 1,4-dioxane. The combined filtrates were evaporated and purified by flash column chromatography (neat hexane to 1:1 hexane/EtOAc gradient containing 2.5percent by volume Et3N) to furnish the biarylanilines 13, 14 and 15.
Reference: [1] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 8, p. 2742 - 2750
[2] Tetrahedron Letters, 2005, vol. 46, # 20, p. 3573 - 3577
[3] New Journal of Chemistry, 2017, vol. 41, # 24, p. 15420 - 15432
  • 20
  • [ 45644-21-1 ]
  • [ 73896-36-3 ]
Reference: [1] Australian Journal of Chemistry, 1982, vol. 35, # 10, p. 2025 - 2034
  • 21
  • [ 45644-21-1 ]
  • [ 76629-10-2 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1980, vol. 17, # 6, p. 1225 - 1229
[2] Patent: EP3287441, 2018, A1,
  • 22
  • [ 45644-21-1 ]
  • [ 15944-34-0 ]
Reference: [1] Patent: WO2017/211759, 2017, A1,
  • 23
  • [ 45644-21-1 ]
  • [ 3282-30-2 ]
  • [ 86847-84-9 ]
YieldReaction ConditionsOperation in experiment
98% With triethylamine In dichloromethane at 0 - 20℃; for 5 h; To a suspension of 6-chloro-pyridin-2-ylamine 13-1 (0.30 g, 2.33 mmol) and triethlyamine (0.41 mL, 2.92 mmol) in anhydrous methylene chloride at 0 °C was added a solution of trichloromethylacetyl chloride (0.32 mL, 2.57 mmol) in anhydrous methylene chloride. The mixture was stirred at 0 °C for 50 min, before allowing it to gradually warm up to room temperature. After 5 h, the reaction mixture was poured into water and the organic phase separated. The aqueous layer was extracted with methylene chloride and the combined organic phases were dried and concentrated. The product was purified by flash chromatography using Combiflash.(R). employing a gradient of 0-15percent EtOAc in Hexanes to afford 0.48 g (2.28 mmol, 98percent yield) of 13-2 as a white solid.
92% With triethylamine In toluene at 20 - 50℃; for 22 h; Example 2; l-({4-[([l,3]Oxathiolo[5,4-c]pyridin-6-ylmethyl)amino]-l- piperidinyl} methyl)- 1 ,2-dihydro-4H,9H-imidazo [1 ,2,3-ij ] -1 ,8-naphthyridine-4,9- dione hydrochloride; (a) λ/-(6-Chloro-2-pyridinyl)-2,2-dimethylpropanamide; A solution of 6-chloro-2-pyridinamine (13.776g, 107 mmol) in toluene (100ml) and triethylamine (16.28ml, 118 mmol) at 500C under argon was treated with 2,2- dimethylpropanoyl chloride (13.81ml, 112mmol). The reaction was then stirred at 500C for 4h and then at rt for 18h. 2M HCl (200ml) was then added and the mixture was extracted with diethyl ether (3 x 500ml). The organic extracts were dried (MgSO4), filtered and evaporated to give the product as a brown solid (21.005g, 92percent). MS (ES+) m/z 213/215 (MH+).
87% With sodium hydrogencarbonate In toluene at 0 - 20℃; for 5 h; To a solution of 2-amino-6-chloropyridine (10.7 g, 83.5 mmol) in toluene (103 mL) NaHCO3 (14 g, 167 mmol) and pivaloyl chloride (15.4 mL, 125.2 mmol) were added at 0°C. The resulting mixture was stirred at room temperature for 5 hours then the suspension was filtered and the solid was washed with DCM. The filtrates were concentrated undervacuum then heptane (22 mL) was added and the resulting mixture was concentrated. The solid was filtered, washed with heptane (15 mL) and dried under vacuum to afford the title intermediate (15.4 g, 72.4 mmol, 87percent yield). LC-MS (M-H) = 213.2
81%
Stage #1: With triethylamine In dichloromethane at 20℃; Cooling with ice
Stage #2: With sodium hydrogencarbonate In dichloromethane; water
Synthesis of compound 3[0120] Pivaloyl chloride (18.7 mL, 151.6 mmol) was slowly added to an ice-cooled solution of 6-chloropyridin-2-amine (15 g, 116.7 mmol) and triethylamine (24.25 mL, 124.96 mmol) in DCM (180 mL). The mixture was stirred in an ice-bath for 15 min and then at rt for 6 h. The mixture was poured into water. The organic layer was washed with saturated aq NaHC03, brine, dried over anhydrous Na2S04; filtered and concentrated in vacuo to give N-(6- chloropyridin-2-yl)pivalamide (intermediate 5) (20.01 g, 81percent) as a yellow solid.
77.7% With triethylamine In toluene at 60℃; for 16 h; To a solution of 10.1 (7.0 g, 54.54 mmol, 1.0 equiv) and pivaloyl chloride (6.7 mL, 57.0 mmol, 1.05 equiv) in toluene was added Et3N (7.7 mL, 57.0 mmol, 2.5 equiv) and stirred at 60° C. for 16 hours.
Upon completion, reaction mixture was poured into water (500 mL) and extracted with EtOAc (200 mL*3).
Organic layers were combined, dried over sodium sulphate and concentrated under reduced pressure to obtain crude which was purified by column chromatography to provide pure 10.2 (9.0 g, 77.7percent). MS (ES): m/z 213.3 [M+H]+.

Reference: [1] Patent: WO2011/50245, 2011, A1, . Location in patent: Page/Page column 118
[2] Patent: WO2008/128942, 2008, A1, . Location in patent: Page/Page column 33
[3] Journal of Medicinal Chemistry, 2000, vol. 43, # 16, p. 3134 - 3147
[4] Patent: WO2017/211759, 2017, A1, . Location in patent: Page/Page column 92
[5] Organic Process Research and Development, 2009, vol. 13, # 3, p. 555 - 566
[6] Patent: WO2012/3418, 2012, A2, . Location in patent: Page/Page column 47
[7] Journal of Organic Chemistry, 1983, vol. 48, # 20, p. 3401 - 3408
[8] Patent: US2016/251376, 2016, A1, . Location in patent: Paragraph 0431; 0432; 0433
[9] Journal of Organic Chemistry, 2005, vol. 70, # 5, p. 1771 - 1779
[10] Patent: WO2006/59164, 2006, A2, . Location in patent: Page/Page column 22
[11] Patent: WO2011/71725, 2011, A1, . Location in patent: Page/Page column 49
[12] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 23, p. 7107 - 7112
[13] Patent: CN105294688, 2016, A, . Location in patent: Paragraph 0031-0033
[14] Patent: WO2004/104001, 2004, A2, . Location in patent: Page 71
  • 24
  • [ 45644-21-1 ]
  • [ 127446-34-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2000, vol. 43, # 16, p. 3134 - 3147
[2] Patent: WO2012/3418, 2012, A2,
[3] Patent: WO2017/211759, 2017, A1,
  • 25
  • [ 45644-21-1 ]
  • [ 84487-03-6 ]
YieldReaction ConditionsOperation in experiment
34% at 0℃; for 4 h; Conc. HNO3 (2.39 mL, 35.00 mmol) was added dropwise to a mixture of cone H2SO4 (56 mL, 1050 mmol) and 6-chloropyridin-2-amine (3.00 g, 23.34 mmol) at 0 °C. The mixture was stirred at 0 °C for 4 h and poured into ice-water. The mixture was extracted with EtOAc (3x100 mL). The combined organic layers were dried over anhydrous Na2S04 and concentrated. The residue was purified by chromatography to give the sub-title compound (1.38 g, 34 percent).
34% at 0℃; for 4 h; Cone. HNO3 (2.39 ml_, 35.00 mmol) was added dropwise to a mixture of cone H2SO4 (56 ml_, 1050 mmol) and 6-chloropyridin-2-amine (3.00 g, 23.34 mmol) at 0 °C. The mixture was stirred at 0 °C for 4 h and poured into ice-water. The mixture was extracted with EtOAc (3x100 ml_). The combined organic layers were dried over anhydrous Na2S04 and concentrated. The residue was purified by chromatography to give the sub-title compound (1.38 g, 34 percent).
Reference: [1] Patent: WO2018/146472, 2018, A1, . Location in patent: Page/Page column 54; 55
[2] Patent: WO2018/146469, 2018, A1, . Location in patent: Page/Page column 44-45
  • 26
  • [ 45644-21-1 ]
  • [ 24424-99-5 ]
  • [ 159603-71-1 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With sodium hexamethyldisilazane In tetrahydrofuran at 20℃; Inert atmosphere
Stage #2: With hydrogenchloride In water; ethyl acetate
tert-butyl (6-chloro-pyridin-2-yl)-carbamate Under a nitrogen atmosphere a solution of 32.7 g (0.15 mol) BOC anhydride in 100 mL THF was added dropwise at RT to 17.4 g (0.14 mol) 6-chloro-pyridin-2-ylamine and 300 mL (0.30 mol) of a 1 molar sodium hexamethyldisilazide solution in THF in 200 mL THF. The reaction mixture was stirred overnight at RT and then evaporated down. The residue was stirred between EtOAc and 1N aqueous hydrochloric acid solution. The organic phase was separated off and the aqueous phase was again extracted with EtOAc. The combined organic phases were washed with 300 mL saturated sodium hydrogen carbonate solution, dried and evaporated down. The residue was recrystallised from EtOH, the solid was suction filtered and dried.Yield: 29.2 g (95percent of theoretical)ESI-MS: m/z=228 (M+)Rt(HPLC): 1.70 min (method C)
95% With sodium hexamethyldisilazane In tetrahydrofuran at 20℃; Inert atmosphere Step 1: tert-butyl (6-chloro-pyridin-2-yl)-carbamate; Under a nitrogen atmosphere a solution of 32.7 g (0.150 mol) BOC-anhydride in 100 mL THF was added dropwise at RT to a mixture of 17.4 g (0.135 mol) 6-chloropyridin-2-ylamine and 300 mL (0.300 mol) of a sodium hexamethyldisilazide solution (1M in THF) in 200 mL of THF. The reaction mixture was stirred overnight at RT and evaporated down i.vac. The residue was stirred between EtOAc and 1N aqueous hydrochloric acid solution. The organic phase was separated off and the aqueous phase was extracted with EtOAc. The combined organic phases were washed with saturated sodium hydrogen carbonate solution, dried and evaporated down. The residue was recrystallised from EtOH, the solid was suction filtered and dried.Yield: 29.2 g (95percent of theoretical)ESI-MS: m/z=228 (M+)Rt(HPLC): 1.70 min (method B)
95% With sodium hexamethyldisilazane In tetrahydrofuran at 20℃; Inert atmosphere Step 1: tert-butyl (6-chloro-pyridin-2-yl)-carbamate Under a nitrogen atmosphere a solution of 32.74 g (0.15 mol) BOC anhydride in 100 mL THF was added dropwise at RT to 17.36 g (0.14 mol) 6-chloro-pyridin-2-ylamine and 300 mL (0.30 mol) of a 1 molar sodium hexamethyldisilazide solution in THF in 200 mL THF. The reaction mixture was stirred overnight at RT and then evaporated down. The residue was stirred between EtOAc and 1 N aqueous hydrochloric acid solution. The organic phase was separated off and the aqueous phase was extracted again with EtOAc. The combined organic phases were washed with 300 mL saturated sodium hydrogen carbonate solution, dried and evaporated down. The residue was recrystallised from EtOH, the solid was suction filtered and dried overnight in the drying cupboard at 50° C.Yield: 29.20 g (95percent of theoretical)ESI-MS: m/z=228 (M+)Rt(HPLC): 1.70 min (method C)
88% With sodium hexamethyldisilazane In tetrahydrofuran at 0 - 20℃; for 0.5 h; Example 11A
tert-Butyl (6-chloropyridin-2-yl)carbamate
Under argon, 150 ml of THF were added to 23.4 g (181.8 mmol) of 2-chloro-5-aminopyridine, and the mixture was cooled to 0° C. 73.3 g (400 mmol) of sodium bis(trimethylsilyl)amide and 43.65 g (200 mmol) of di-tert-butyl dicarbonate, dissolved in 150 ml of THF, were added dropwise.
After 15 min, the cooling bath was removed, and stirring was continued at RT for 15 min.
The THF was removed using a rotary evaporator, ethyl acetate and 0.5 N hydrochloric acid were added to the residue and the mixture was extracted.
The organic phase was separated off, dried over magnesium sulphate and concentrated using a rotary evaporator.
The reaction mixture was chromatographed on silica gel (mobile phase dichloromethane/methanol 100percent-->100:3).
This gave 36.54 g (88percent of theory) of the product as a solid.
LCMS (method 3): Rt=2.41 min. (m/z=175 (M+H)+).
1H-NMR (400 MHz, DMSO-d6): δ=10.11 (s, 1H), 7.78 (d, 2H), 7.1 (t, 1H), 1.47 (s, 9H).
88% With sodium hexamethyldisilazane In tetrahydrofuran at 0 - 20℃; Inert atmosphere Example 105Atert-Butyl (6-chloropyridin-2-yl)carbamate 23.4 g (181.8 mmol) of 2-chloro-5-aminopyridine are mixed with 150 ml of THF under argon and cooled to 0° C. 73.3 g (400 mmol) of bis(trimethylsilyl)sodium amide and 43.65 g (200 mmol) of di-tert-butyl dicarbonate, dissolved in 150 ml of THF, are added dropwise. After 15 min, the cooling bath is removed and stirring is continued at RT for 15 min. The THF is removed in a rotary evaporator, and the residue is mixed and extracted with ethyl acetate and 0.5 N hydrochloric acid. The organic phase is separated off, dried over magnesium sulphate and concentrated in a rotary evaporator. The reaction mixture is chromatographed on silica gel (mobile phase dichloromethane/methanol 100percent-->100:3). 36.54 g (88percent of theory) of the product are obtained as a solid.LCMS (method 3): Rt=2.41 min. (m/z=175 (M+H)+).1H-NMR (400 MHz, DMSO-d6): d=10.11 (s, 1H), 7.78 (d, 2H), 7.1 (t, 1H), 1.47 (s, 9H).
88% With sodium hexamethyldisilazane In tetrahydrofuran at 0 - 20℃; for 0.5 h; Inert atmosphere Example 3Atert-Butyl(6-chloropyridin-2-yl)carbamate; Under argon, 150 ml of THF were added to 23.4 g (181.8 mmol) of 2-chloro-5-aminopyridine, and the mixture was cooled to 0° C. 73.3 g (400 mmol) of sodium bis(trimethylsilyl)amide and 43.65 g (200 mmol) of di-tert-butyl dicarbonate, dissolved in 150 ml of THF, were added dropwise. After 15 min, the cooling bath was removed and stirring was continued at RT for 15 min. The THF was removed on a rotary evaporator, ethyl acetate and 0.5N hydrochloric acid were added to the residue and the mixture was extracted. The organic phase was separated off, dried over magnesium sulfate and concentrated on a rotary evaporator. The reaction mixture was chromatographed on silica gel (mobile phase dichloromethane/methanol 100percent-->100:3). This gave 36.54 g (88percent of theory) of the product as a solid.LCMS (Method 3): Rt=2.41 min. (m/z=175 (M+H)+).1H-NMR (400 MHz, DMSO-d6): δ=10.11 (s, 1H), 7.78 (d, 2H), 7.1 (t, 1H), 1.47 (s, 9H).
88% With sodium hexamethyldisilazane In tetrahydrofuran at 0 - 20℃; for 0.5 h; Inert atmosphere Example 1A
tert-Butyl (6-chloropyridin-2-yl)carbamate
23.4 g (181.8 mmol) of 2-chloro-5-aminopyridine were admixed with 150 ml of THF under argon and cooled to 0° C. 73.3 g (400 mmol) of sodium bis(trimethylsilyl)amide and 43.65 g (200 mmol) of di-tert-butyl dicarbonate, dissolved in 150 ml of THF, were added dropwise.
After 15 min, the cooling bath was removed and the mixture was stirred at RT for a further 15 min.
The THF was removed by rotary evaporation, and the residue was admixed and extracted with ethyl acetate and 0.5 N hydrochloric acid.
The organic phase was removed, dried over magnesium sulphate and concentrated on a rotary evaporator.
The reaction mixture was chromatographed on silica gel (eluent: dichloromethane/methanol 100percent→100:3).
36.54 g (88percent of theory) of the product were obtained in solid form.
LCMS (method 3): Rt=2.41 min (m/z=175 (M+H)+).
1H NMR (400 MHz, DMSO-d6): δ=10.11 (s, 1H), 7.78 (d, 2H), 7.1 (t, 1H), 1.47 (s, 9H).
87.4%
Stage #1: With sodium hexamethyldisilazane In tetrahydrofuran at 0℃; for 0.0833333 h; Inert atmosphere
Stage #2: at 0 - 20℃; for 1 h;
Sodium hexamethyl disilazane (63.03 g, 343 mmol) was added portion-wise to a stirred solution of 2-chloro-6-aminopyridine (20.0 g, 156.25 mmol) in THF (100 mL) at 0° C. under argon.
After 5 minutes of stirring at the same temperature, di-tertiary-butyl dicarbonate (36.77 mL, 171 mmol) was added drop-wise into the reaction mixture.
After 15 minutes of additional stirring at the same temperature, the reaction temperature was brought to room temperature and stirred until starting material was consumed completely (1 hour, monitored by silica gel TLC using ethyl acetate-hexanes, 1:9 as mobile phase).
THF was distilled off under reduced pressure, the obtained residue was taken up in ethyl acetate (300 mL), washed with an aqueous solution of 0.5 M HCl (100 mL), water (2*75 mL), dried over anhydrous sodium sulfate, filtered and concentrated on the rotary evaporator to obtain a gummy mass, which was purified over silica gel column chromatography (eluant:EtOAc-hexanes, 1:19) to give (6-chloro-pyridin-2-yl)-carbamic acid tert-butyl ester as a white solid. (Yield 31.0 g, 87.4percent).
63.4%
Stage #1: With sodium hexamethyldisilazane In tetrahydrofuran at 0℃;
Stage #2: at 0 - 20℃; for 1 h;
NaHMDS (351 ml, 0.7mol) in THF (300 ml) was cooled to 0 °C, a solution of 2-amino-6- chloropyridine (107; 40 g, 0.3 1 1 mol) in THF (300 ml) was added, followed by a solution of di- tert-butyl dicarbonate(68 g, 0.3 1 1 mol) in THF, ensuring the internal temperature remained below 0 °C. The resulting reaction mixture was aged for 1 h at room temp and then careful ly acidified to pH 3 by addition of 1 M hydrochloric acid, extracted with EtOAc, the combined organic layers were then washed sequentially with saturated aqueous NaHCCh and brine, dried over Na2S04, filtered, concentrated to afford crude product, Triturated with ether to afforded desired product tert-butyl 6-chloropyridin-2-ylcarbamate (108; 45g, yield 63.4percent). M S (ESI) calcd for C,oH,3CIN202 (m/z) 228.69.

Reference: [1] Patent: US2011/21500, 2011, A1, . Location in patent: Page/Page column 45
[2] Patent: US2011/172218, 2011, A1, . Location in patent: Page/Page column 29
[3] Patent: US2012/149698, 2012, A1, . Location in patent: Page/Page column 26
[4] Journal of Organic Chemistry, 2005, vol. 70, # 5, p. 1771 - 1779
[5] Patent: US2009/258877, 2009, A1, . Location in patent: Page/Page column 16-17
[6] Patent: US2010/113441, 2010, A1, . Location in patent: Page/Page column 48
[7] Patent: US2011/144131, 2011, A1, . Location in patent: Page/Page column 19
[8] Patent: US2011/190316, 2011, A1, . Location in patent: Page/Page column 11
[9] Patent: US2012/184562, 2012, A1, . Location in patent: Page/Page column 8; 34; 35
[10] Journal of Medicinal Chemistry, 2000, vol. 43, # 16, p. 3134 - 3147
[11] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 22, p. 6368 - 6372
[12] Patent: WO2011/59839, 2011, A1, . Location in patent: Page/Page column 112-113
[13] Patent: US5410057, 1995, A,
[14] Patent: WO2007/16087, 2007, A2, . Location in patent: Page/Page column 49; 65
[15] Patent: WO2006/41830, 2006, A2, . Location in patent: Page/Page column 54-55
[16] Patent: WO2006/44504, 2006, A1, . Location in patent: Page/Page column 79
[17] Patent: WO2006/99268, 2006, A2, . Location in patent: Page/Page column 65
[18] Patent: CN104987333, 2017, B, . Location in patent: Paragraph 0029; 0030; 0042; 0049; 0056
[19] Patent: US2018/50992, 2018, A1, . Location in patent: Paragraph 1391
  • 27
  • [ 45644-21-1 ]
  • [ 75-44-5 ]
  • [ 75-65-0 ]
  • [ 159603-71-1 ]
Reference: [1] Patent: US2013/5981, 2013, A1, . Location in patent: Page/Page column 9
  • 28
  • [ 45644-21-1 ]
  • [ 883984-95-0 ]
Reference: [1] Patent: US2011/172218, 2011, A1,
[2] Patent: US2012/149698, 2012, A1,
[3] Patent: US2018/50992, 2018, A1,
  • 29
  • [ 45644-21-1 ]
  • [ 442127-50-6 ]
YieldReaction ConditionsOperation in experiment
25.5% With bromine In chloroform at 0 - 20℃; for 16 h; To a solution of 2-amino-6-chloropyridine (15g, 116mmol) in chloroform (600ml) was added a solution of bromine (4.2g, 965mmol) in chloroform (50ml) at 0°C and the reaction mixture wasstirred at room temperature for 16h. After completion of reaction, the reaction was quenched over ice cold water; extracted to DCM and concentrated to obtain the crude compound. The crude compound was purified by silica gel column chromatography using 10percent ethyl acetate in hexane as eluent to afford the title compound (6.2g, 25.5percent). LCMS: m/z = 209.0 (M+1)+.
17% With bromine In chloroform A.1 3-Bromo-6-chloro-pyridin-2-ylamine[0328] 6-Chloro-pyridin-2-ylamine (5g, 38.89 mmol) is dissolved in chloroform (250 mL) and a solution of bromine (1.33 mL, 26 mmol) in chloroform (50 mL) is slowly added over a one hour period. During the addition a precipitate (hydrobromide salt of the starting material) forms. After stirring overnight the reaction mixture is filtered, the filtrate is evaporated and the residue is partitioned between ethyl acetate and 1 M sodium carbonate solution. The organic phase is separated, evaporated and the solid residue purified by flash chromatography (silica gel, 15 percent ethyl acetate in petroleum ether) affording the title compound (1.44 g, 17 percent) as a solid. The material is carried through the next three reaction steps.
Reference: [1] Patent: WO2017/9806, 2017, A1, . Location in patent: Page/Page column 69
[2] Patent: WO2008/65198, 2008, A1, . Location in patent: Page/Page column 68
  • 30
  • [ 45644-21-1 ]
  • [ 1038866-44-2 ]
Reference: [1] Patent: US2012/149698, 2012, A1,
  • 31
  • [ 45644-21-1 ]
  • [ 52471-07-5 ]
Reference: [1] Patent: US2011/190316, 2011, A1,
  • 32
  • [ 45644-21-1 ]
  • [ 1221398-11-3 ]
YieldReaction ConditionsOperation in experiment
75% With N-iodo-succinimide In N,N-dimethyl-formamide at 20℃; for 12 h; To a solution of 6-chloropyridin-2-amine (50.0 g, 389 mmol) in DMF (700 mL) was added N-iodosuccinimide (105 g, 467 mmol).
The brown solution was stirred at rt for 12 h.
The mixture was poured into water (2.1 L) and filtered.
The filter cake was washed with water (2*500 mL) and then dried under vacuum.
Purification (FCC, SiO2; 5-20percent EtOAc/petroleum ether) afforded the title compound (83 g, 75percent) as a pink solid. MS (ESI): mass calcd. for C5H4ClIN2, 253.9; m/z found, 254.7 [M+H]+. 1H NMR (400 MHz, CDCl3) δ 7.74 (d, J=8.0 Hz, 1H), 6.20 (d, J=8.0 Hz, 1H), 4.69 (br s, 2H).
73% With N-iodo-succinimide In N,N-dimethyl-formamide for 43 h; 36 (1.00g, 7.78mmol) was dissolved in DMF (40mL), the reaction flask was covered with aluminium foil, and NIS (970mg, 4.28mmol) was added. The reaction mixture was stirred for 19h before additional NIS (970mg, 4.28mmol) was added, and the reaction mixture was stirred for another 24h. H2O (200mL) was added, and the mixture was extracted with EtOAc (2×250mL). The combined organic layer was washed with H2O (2×200mL) and brine (200mL), dried over Na2SO4, and evaporated under vacuum. Recrystallization from EtOH followed by recrystallization of the mother liquor afforded the product as orange, needle-shaped crystals (1.45g, 73percent). mp 154.3–155.9. 1H NMR (CDCl3) δ 7.75 (d, J=8.2Hz, 1H), 6.22 (d, J=8.2Hz, 1H). 13C NMR (CDCl3) δ 157.6, 151.6, 149.4, 108.8.
0.49 g With N-iodo-succinimide In N,N-dimethyl-formamide at 20℃; for 16 h; To an N,N-dimethylformamide (30 mL) solution of 2-amino-6-chloropyridine (1.0 g) was added N-iodosuccinimide (1.75 g) and the mixture stirred at room temperature for 16 hours. To the reaction mixture, water (200 mL) was added followed by extraction into ethyl acetate. The combined organic layers were dried, filtered and concentrated. The residue was triturated with dichloromethane and the resultant precipitate collected by filtration to give the title compound having the following physical properties (0.49 g). LC/MS tR 1.72 minutes; MS (ES+) m/z 254 (M+H) a.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 5, p. 1697 - 1700
[2] Patent: US2018/111933, 2018, A1, . Location in patent: Paragraph 0243
[3] European Journal of Medicinal Chemistry, 2014, vol. 84, p. 404 - 416
[4] Patent: WO2013/93484, 2013, A1, . Location in patent: Page/Page column 243
[5] Patent: WO2016/168098, 2016, A1, . Location in patent: Page/Page column 50
  • 33
  • [ 45644-21-1 ]
  • [ 1221398-11-3 ]
YieldReaction ConditionsOperation in experiment
6.1 g at 80℃; for 4 h; 2-chloro-6-aminopyridine (23.0 g, 178 mmol) and potassium acetate (17.5 g, 178 mmol) were dissolved in 200 mL acetic acid and heated to 80° C. A solution of ICl (29.05 g, 178 mmol) in acetic acid (40 mL) was added dropwise and the reaction mixture was stirred at 80° C. for 4 h. The reaction mixture was cooled to room temperature and the acetic acid was removed under reduced pressure. The residue was dissolved in ethyl acetate and neutralized by saturated aq. NaHCO3solution. The organic layer was washed with saturated aq. NaHSO3, dried over Na2SO4, concentrated and purified by silica column using hexanes and ethyl acetate as eluent. Isolated 6.1 g of title compound.
Reference: [1] Patent: CN102449107, 2016, B, . Location in patent: Paragraph 0332; 0333; 0334
  • 34
  • [ 45644-21-1 ]
  • [ 53554-20-4 ]
Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 84, p. 404 - 416
  • 35
  • [ 45644-21-1 ]
  • [ 1303588-27-3 ]
Reference: [1] Patent: WO2011/59839, 2011, A1,
  • 36
  • [ 45644-21-1 ]
  • [ 1261269-84-4 ]
Reference: [1] Patent: WO2011/112995, 2011, A1, . Location in patent: Page/Page column 74; 75
[2] Patent: US2014/148430, 2014, A1, . Location in patent: Paragraph 0386
  • 37
  • [ 45644-21-1 ]
  • [ 1448428-04-3 ]
Reference: [1] Patent: WO2016/106384, 2016, A1,
[2] Patent: WO2016/106384, 2016, A1,
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 45644-21-1 ]

Filgotinib Related Intermediates

Chemical Structure| 39093-93-1

[ 39093-93-1 ]

Thiomorpholine 1,1-dioxide

Chemical Structure| 1010120-55-4

[ 1010120-55-4 ]

5-Bromo[1,2,4]triazolo[1,5-a]pyridin-2-amine

Chemical Structure| 159603-71-1

[ 159603-71-1 ]

tert-Butyl (6-chloropyridin-2-yl)carbamate

Chemical Structure| 19798-81-3

[ 19798-81-3 ]

6-Bromopyridin-2-amine

Chemical Structure| 59016-93-2

[ 59016-93-2 ]

4-(Hydroxymethyl)benzeneboronic acid

Related Functional Groups of
[ 45644-21-1 ]

Chlorides

Chemical Structure| 5193-03-3

[ 5193-03-3 ]

2-Chloro-6-hydrazinopyridine

Similarity: 0.87

Chemical Structure| 52413-76-0

[ 52413-76-0 ]

2-Amino-6-chloroisonicotinonitrile

Similarity: 0.77

Chemical Structure| 52471-07-5

[ 52471-07-5 ]

2-Amino-6-chloronicotinonitrile

Similarity: 0.75

Chemical Structure| 3678-62-4

[ 3678-62-4 ]

2-Chloro-4-methylpyridine

Similarity: 0.73

Chemical Structure| 16110-09-1

[ 16110-09-1 ]

2,5-Dichloropyridine

Similarity: 0.73

Amines

Chemical Structure| 5193-03-3

[ 5193-03-3 ]

2-Chloro-6-hydrazinopyridine

Similarity: 0.87

Chemical Structure| 52413-76-0

[ 52413-76-0 ]

2-Amino-6-chloroisonicotinonitrile

Similarity: 0.77

Chemical Structure| 52471-07-5

[ 52471-07-5 ]

2-Amino-6-chloronicotinonitrile

Similarity: 0.75

Chemical Structure| 5350-93-6

[ 5350-93-6 ]

6-Chloropyridin-3-amine

Similarity: 0.69

Chemical Structure| 6298-19-7

[ 6298-19-7 ]

2-Chloropyridin-3-amine

Similarity: 0.67

Related Parent Nucleus of
[ 45644-21-1 ]

Pyridines

Chemical Structure| 5193-03-3

[ 5193-03-3 ]

2-Chloro-6-hydrazinopyridine

Similarity: 0.87

Chemical Structure| 52413-76-0

[ 52413-76-0 ]

2-Amino-6-chloroisonicotinonitrile

Similarity: 0.77

Chemical Structure| 52471-07-5

[ 52471-07-5 ]

2-Amino-6-chloronicotinonitrile

Similarity: 0.75

Chemical Structure| 3678-62-4

[ 3678-62-4 ]

2-Chloro-4-methylpyridine

Similarity: 0.73

Chemical Structure| 16110-09-1

[ 16110-09-1 ]

2,5-Dichloropyridine

Similarity: 0.73